Currently approved GLP-1 agonists, including liraglutide, semaglutide, dulaglutide and lixisenatide, as well as exendin-4 have been examined for bias between cAMP and -arrestin-2 recruitment [75]
The muscle and joint pain that characterizes psoriatic arthritis appears responsive to the anti-inflammatory effects
Research from the SURMOUNT clinical trials showed that tirzepatide patients lost significantly more visceral fat compared to placebo groups, a finding that correlates with the GIP receptor activity
In clinical trials involving patients with type 2 diabetes, constipation was reported by 3.1% to 5% of those receiving the injection and 5% to 6% of those taking the tablet form
J., Walker, C., Murray, A